Fabio Giglio

2.2k total citations
47 papers, 705 citations indexed

About

Fabio Giglio is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Fabio Giglio has authored 47 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 18 papers in Oncology and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Fabio Giglio's work include Hematopoietic Stem Cell Transplantation (19 papers), Acute Lymphoblastic Leukemia research (16 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Fabio Giglio is often cited by papers focused on Hematopoietic Stem Cell Transplantation (19 papers), Acute Lymphoblastic Leukemia research (16 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Fabio Giglio collaborates with scholars based in Italy, United States and Germany. Fabio Giglio's co-authors include Fabio Ciceri, Jacopo Peccatori, Chiara Bonini, Raffaella Greco, Maria Teresa Lupo Stanghellini, Francesca Lorentino, Andrea Assanelli, Mara Morelli, Consuelo Corti and Simona Piemontese and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Fabio Giglio

43 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fabio Giglio Italy	14	402	338	308	85	77	47	705
Woo Sung Min South Korea	16	389 1.0×	197 0.6×	241 0.8×	81 1.0×	123 1.6×	47	696
Anu Korula India	14	394 1.0×	118 0.3×	209 0.7×	142 1.7×	202 2.6×	112	724
Viki Anders United States	11	489 1.2×	259 0.8×	97 0.3×	67 0.8×	26 0.3×	12	622
Fleur M. Aung United States	14	413 1.0×	230 0.7×	89 0.3×	45 0.5×	46 0.6×	32	595
Hisaki Fujii Japan	15	176 0.4×	148 0.4×	155 0.5×	114 1.3×	143 1.9×	33	580
Claudia Rutt Germany	13	407 1.0×	285 0.8×	131 0.4×	62 0.7×	42 0.5×	22	664
Lisa Brennan United States	8	295 0.7×	323 1.0×	125 0.4×	29 0.3×	30 0.4×	14	590
Makoto Yazaki Japan	13	269 0.7×	203 0.6×	106 0.3×	139 1.6×	116 1.5×	33	547
Nathan Cantoni Switzerland	11	275 0.7×	157 0.5×	105 0.3×	37 0.4×	80 1.0×	32	496
Sinem Civriz Bozdağ Türkiye	10	214 0.5×	71 0.2×	114 0.4×	63 0.7×	43 0.6×	61	397

Countries citing papers authored by Fabio Giglio

Since Specialization

Citations

This map shows the geographic impact of Fabio Giglio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Giglio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Giglio more than expected).

Fields of papers citing papers by Fabio Giglio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio Giglio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Giglio. The network helps show where Fabio Giglio may publish in the future.

Co-authorship network of co-authors of Fabio Giglio

This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Giglio. A scholar is included among the top collaborators of Fabio Giglio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio Giglio. Fabio Giglio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Candoni, Anna, Patrizia Chiusolo, Davide Lazzarotto, et al.. (2024). Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission. Cancers. 16(11). 2108–2108. 3 indexed citations

Käyser, Sabine, Chiara Sartor, Fabio Giglio, et al.. (2023). Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease. Haematologica. 109(5). 1385–1392. 3 indexed citations

Giglio, Fabio, Francesca Lorentino, Maddalena Noviello, et al.. (2023). Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia. Frontiers in Oncology. 12. 1100105–1100105.

Giglio, Fabio, Elisabetta Xue, Angelica Barone, et al.. (2023). Intrabone Transplantation of a Single Unwashed Umbilical Cord Blood Unit with Antithymocyte Globulin-Free and Sirolimus-Based Graft-versus-Host Disease Prophylaxis: Fast Immune Reconstitution and Long-Term Disease Control in Patients with High-Risk Diseases. Transplantation and Cellular Therapy. 29(8). 519.e1–519.e9. 1 indexed citations

Clerici, Daniela, et al.. (2022). Peripheral blood smear diagnosis of G6PD deficiency in an 83‐year‐old man. SHILAP Revista de lepidopterología. 4(1). 276–277. 1 indexed citations

Käyser, Sabine, Chiara Sartor, Marlise R. Luskin, et al.. (2022). Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin. Haematologica. 107(9). 2064–2071. 14 indexed citations

Lorentino, Francesca, Alessandro Bruno, Sarah Marktel, et al.. (2022). Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis. Haematologica. 107(11). 2748–2751. 1 indexed citations

Stanghellini, Maria Teresa Lupo, Simona Piemontese, Andrea Assanelli, et al.. (2021). Second Solid Cancers After Hematopoietic Stem Cell Transplantation: Active Surveillance During Long-term Follow-up. HemaSphere. 5(11). e654–e654.

Ruggeri, Annalisa, Maria Teresa Lupo Stanghellini, Sara Mastaglio, et al.. (2021). Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial. Frontiers in Oncology. 11. 731478–731478. 7 indexed citations

10.

Cugno, Massimo, Silvia Berra, Silvana Tedeschi, et al.. (2021). IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome. Journal of the American Society of Nephrology. 32(5). 1227–1235. 15 indexed citations

11.

Ciceri, Fabio, et al.. (2021). Complicated and persistent severe COVID-19 pneumonia in a recipient of allogeneic haematopoietic stem cell transplant. BMJ Case Reports. 14(10). e245992–e245992. 5 indexed citations

12.

Arcangeli, Silvia, Laura Falcone, Barbara Camisa, et al.. (2020). Next-Generation Manufacturing Protocols Enriching TSCM CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients. Frontiers in Immunology. 11. 1217–1217. 96 indexed citations

13.

Oltolini, Chiara, Raffaella Greco, Laura Galli, et al.. (2020). Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching. Biology of Blood and Marrow Transplantation. 26(6). 1179–1188. 34 indexed citations

14.

Migliavacca, Maddalena, Andrea Assanelli, Maurilio Ponzoni, et al.. (2018). First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature. Frontiers in Immunology. 9. 113–113. 21 indexed citations

15.

Greco, Raffaella, Francesca Lorentino, Mara Morelli, et al.. (2016). Posttransplantation cyclophosphamide and sirolimus for prevention of GVHD after HLA-matched PBSC transplantation. Blood. 128(11). 1528–1531. 30 indexed citations

16.

Forcina, Alessandra, Francesca Lorentino, Raffaella Greco, et al.. (2016). Pre-Transplant Colonization By a Multidrug-Resistant Gram Negative Bacteria Has No Impact on Overall Survival and Mortality after Hematopoietic Stem Cell Transplantation: A Single-Center Experience in 362 Patients. Blood. 128(22). 5743–5743. 1 indexed citations

17.

Greco, Raffaella, Fabio Giglio, Mara Morelli, et al.. (2016). Coadministration of posaconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplantation. 51(7). 1022–1024. 6 indexed citations

18.

Cieri, Nicoletta, Raffaella Greco, Lara Crucitti, et al.. (2015). Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells. Biology of Blood and Marrow Transplantation. 21(8). 1506–1514. 88 indexed citations

19.

Cieri, Nicoletta, Raffaella Greco, Mara Morelli, et al.. (2013). Post-Transplant Cyclophosphamide Haplo-HSCT Revised: Peripheral Blood Stem Cell Graft and Sirolimus To Enhance Immune Reconstitution and Graft Versus Leukemia Effect In Patients With Active Leukemia. Blood. 122(21). 2118–2118. 2 indexed citations

20.

Anastasia, Antonella, Fabio Giglio, Rita Mazza, et al.. (2009). Early discharge after high-dose melphalan and peripheral blood stem cell reinfusion in patients with hematological and non-hematological disease. Leukemia & lymphoma. 50(1). 80–84. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact